SHEENA PATEL: Open Payments
NPI 1427715663 · ARLINGTON HEIGHTS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 30 payments from 14 companies in 2025. Trend: 2023 $614 · 2024 $299 · 2025 $816
Food & beverage: $816
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $122 |
| Janssen Biotech, Inc. | 1 | $122 |
| Alkermes, Inc. | 3 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $77 |
| Neurocrine BioSciences, Inc. | 2 | $72 |
| Lundbeck LLC | 3 | $67 |
| Teva Pharmaceuticals USA, Inc. | 3 | $66 |
| Bausch Health US, LLC | 3 | $45 |
| TMS NeuroHealth Centers Inc. | 1 | $38 |
| Tris Pharma Inc | 2 | $36 |
Products named: VRAYLAR, ERLEADA, CAPLYTA, INGREZZA, AUSTEDO XR, VIVITROL, APLENZIN, ABILIFY ASIMTUFII.
Industry payments across IL — which companies pay providers there.
